GTAC HOME

TREATMENT PREPAREDNESS HOME

MATERIALS

  • ARVs
  • OI's
  • MTCT
  • Immunology
  •  

    ADVOCACY

  • (COMING SOON)
  •  








    TREATMENT PREPAREDNESS

    I. ANTIRETROVIRALS

    intro
    3 different types of fact sheets for each of the following four medications:

    • AZT (retrovir), Nevirapine (Viramune), Nelfinavir (Viracept), 3TC (Epivir)
    • Dosing combination and schedule sheet for all currently available medications
    Why we've chosen these materials
      We've chosen fact sheets that use some typical approaches:
      • evidence-based (ie citing the studies that have been done on a specific drug, as they explain the efficacy)
      • question-and-answer style (addressing a potential patient)
      • one-page summary
      These fact sheets also have a range of levels of technical language, and make a variety of assumptions about pre-existing knowledge. We hope to gather feedback on which approaches are needed, and for which contexts.

    CONTENTS

      AZT
        AZT (pdf format)
        Download PDF

        AZT main page with links for word, pdf and web printing on www.aidsinfonet.org
        View Online

        AZT (webpage only) on www.aidsmap.com
        View Online

      NEVIRAPINE
        Nevirapine (available in pdf)
        Download PDF

        Nevirapine main page with links for word, pdf and web printing on www.aidsinfonet.org
        View Online

        Nevirapine (webpage only) on www.aidsmap.com
        View Online

      NELFINAVIR
        Nelfinavir (webpage only) on www.aidsmap.com. View Online

        Nelfinavir main page with links for word, pdf and web printing on www.aidsinfonet.org
        View Online

        Nelfinavir (available in html and as a pdf) on www.acas.org
        View Online
        Download PDF

      3TC
        3TC (available in pdf)
        Download PDF 3TC main page with links for word, pdf and web printing on www.aidsinfonet.org
        View Online

        3TC (webpage only) on www.aidsmap.org
        View Online

      RESOURCES We need your feedback
      INSTRUCTIONS FOR REVIEWERS
        1) Identify who will participate in review process. Many of these materials will be most useful for individuals providing direct service to people with HIV and AIDS, and affected groups. It would be ideal to include a direct service provider (who may also be a person living with HIV/AIDS) in your review team.

        2) Review materials & Complete survey

        You will find four sub-packets of information.

        • (I) antiretrovirals
        • (II) opportunistic infections
        • (III) Immunology and HIV life cycle basics
        • (IV) mother to child transmission
        Each sub-packet starts with an introduction/explanation of contents. The second sheet is the sheet reviewers should fill out and return to the Materials working group. Please fill out as many of the questions as you can and use righthand column and the reverse side for additional comments.

        You will also find a separate survey (sheet V, white) assessing the need for different types of information on the global context of treatment access today. For this sheet, just check the boxes of the information you want or have already, and indicate translation needs.

      3) Return survey
        Via mail: Emily Bass
        International AIDS Vaccine Initiative
        110 William Street
        New York, NY 10038 USA

        Via email: ebass@iavi.org

        On the web: Fill the forms out online under each topic.

      REVIEWER'S CHECKLIST
      Please mail or email the following back Emily Bass (IAVI, 110 William Street, New York, NY USA, 10038 or ebass@iavi.org)

      • Treatment materials survey review form (2 pages)
      • 4 review forms, (2 pages each) for:
        • Antiretrovirals
        • Opportunistic infections
        • Immunology and HIV lifecycle
        • Mother to child transmission
      • "Global context" survey sheet (1 page)
      • Copies of any materials that you are currently using that you would like to share with the ITP materials working group and participants in the March conference
      • NOTE: All reviewers will receive electronic versions of these forms (in Word format) to facilitate the review process.

       


    . . . . . . . . . . . . . . . . . . . . .
    GO TO INFORMATION:

    . . . . . . . . . . . . . . . . . . . . .


    Back to Top